Status:
COMPLETED
Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease
Lead Sponsor:
The New York Memory Services
Conditions:
Alzheimer Disease
Mild Cognitive Impairment
Eligibility:
All Genders
Brief Summary
The investigators reviewed 12 years of clinical use in an outpatient neurology setting of transcranial magnetic stimulation (TMS) in patients with Alzheimer's disease (AD) and mild cognitive impairmen...
Detailed Description
The investigators compiled demographic, clinical, and neurocognitive data on all patients who had received TMS for any reason in the clinic over a 12-year period. Of 236 patients receiving TMS, 59 pat...
Eligibility Criteria
Inclusion
- Patients meeting the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (NINCDS- ADRDA) criteria for possible or probable Alzheimer's disease.
- Patients meeting the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (NINCDS- ADRDA) criteria for mild cognitive impairment.
- Patients must have undergone at least two standardized neurocognitive batteries before and after beginning TMS.
- Patients must have received greater than or equal to five (5) TMS sessions in less than one year.
Exclusion
- • Patients with dementias from other causes, such as Lewy Body disease.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04771845
Start Date
May 1 2008
End Date
May 30 2020
Last Update
February 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.